Expression of CD27 on peripheral CD4+ T-lymphocytes correlates with the development of severe acute graft-versus-host disease after allogeneic bone marrow transplantation

International Journal of Hematology

Volumn 84, Issue 4, 2006, Pages 367-376

  Yoshida, Hitoshi ^a,b   Maeda, Tetsuo ^a   Ishikawa, Jun ^a   Inoue, Shinya ^a   Matsunaga, Hitomi ^a   Kosugi, Satoru ^a   Shiraga, Masamichi ^a   Oritani, Kenji ^a   Kanakura, Yuzuru ^a   Tomiyama, Yoshiaki ^a  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Acute GVHD; Allogeneic bone marrow transplantation; CD27+ CD27 ratio; CD4+ T lymphocytes; Prediction

Indexed keywords

CD27 ANTIGEN;

ACUTE GRAFT VERSUS HOST DISEASE; ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ANTIGEN EXPRESSION; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; DISEASE SEVERITY; FEMALE; HEMATOLOGIC MALIGNANCY; HUMAN; MALE; PERIPHERAL LYMPHOCYTE; PREDICTION; ACUTE DISEASE; ALLOTRANSPLANTATION; BONE MARROW TRANSPLANTATION; CHEMISTRY; GRAFT VERSUS HOST REACTION; HISTOCOMPATIBILITY; HOSPITALIZATION; LYMPHOCYTE COUNT; MIDDLE AGED; PREDICTION AND FORECASTING; TIME;

ACUTE DISEASE; ADOLESCENT; ADULT; ANTIGENS, CD27; BONE MARROW TRANSPLANTATION; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; GRAFT VS HOST DISEASE; HUMANS; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION, HOMOLOGOUS;

EID: 34247258857     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1532/IJH97.05159     Document Type: Article

References (36)

1. Peggs KS, Mackinnon S. Immune reconstitution following haematopoietic stem cell transplantation. Br J Haematol. 2004;124:407-420.
2. Kolb H-J, Schmid C, Barrett J, Schendel DJ. Graft-versus-leukemia reactions in allogeneic chimeras. Blood. 2004;103:767-776.
3. Theobald M. Allorecognition and graft-versus-host disease. Bone Marrow Transplant. 1995;15:489-498.
4. Ferrara JLM. Pathogenesis of acute graft-versus-host disease: cytokines and cellular effects. J Hematother Stem Cell Res. 2000;9:299-306.
5. Goker H, Haznedaroglu IC, Chao NJ. Acute graft-vs-host disease: pathobiology and management. Exp Hematol. 2001;29:259-277.
6. Riddell SR. Pathogenesis of cytomegalovirus pneumonia in immunocompromised hosts. Semin Respir Infect. 1995;10:199-208.
7. Koc Y, Miller KB, Schenkein DP, et al. Varicella zoster virus infections following allogeneic bone marrow transplantation: frequency, risk factors, and clinical outcome. Biol Blood Marrow Transplant. 2000;6:44-49.
8. Lens SMA, Tesselaar K, van Oers MHJ, van Lier RA. Control of lymphocyte function through CD27-CD70 interaction. Semin Immunol. 1998;10:491-499.
9. Hintzen RQ, van Lier RAW, Lens SMA, Brouwer M, Baars P, van Lier RAW. Regulation of CD27 expression on subsets of mature T-lymphocytes. J Immunol. 1993;151:2426-2435.
10. + T cells. J Exp Med. 1997;186:1407-1418.
11. Lens SMA, de Joug R, Hooibrink B, et al. Phenotype and functions of human B cells expressing CD70 (CD27L). Eur J Immunol. 1996;26:2964-2971.
12. Lens SMA, Baar PA, Hooibrink B, van Oers MHJ, van Lier RAW. Antigen-presenting cell-derived signals determine expression levels of CD70 on primed T cells. Immunology. 1997;90:38-45.
13. Hintzen RQ, Lens SMA, Lammers K, et al. Engagement of CD27 with its ligand (CD70) provides a second signal for T-cell activation. J Immunol. 1995;154:2612-2623.
14. + T lymphocytes. J Immunol. 1995;154:3689-95.
15. Chamnleau MED, ten Berge IJM, Schellekens PTA, Wilmink JM, Hintzen RQ, van Lier RAW. Serum levels of soluble CD27 in renal transplant recipients. Transplantation. 1992;54:932-936.
16. Yazdanbakhsh M, Sartono E, Kruize YCM, et al. Elevated levels of T cell activation antigen CD27 and increased interleukin-4 production in human lymphatic filariasis. Eur J Immunol. 1993;22:993-999.
17. Przepiorka D, Weisdorf D, Martin P, et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant. 1995;15:825-828.
18. McNeel D, Rubio MT, Damaj G, et al. Hypereosinophilia as a presenting sign of acute graft-versus-host disease after allogeneic bone marrow transplantation. Transplantation. 2002;74:1797-1800.
19. Liem LM, van Lopik T, van Nieuwenhuijze AEM, van Houwelingen HC, Aarden L, Goulmy E. Souluble Fas levels in sera of bone marrow transplantation recipients are increased during acute graft-versus-host disease but not during infections. Blood. 1998;91:1464-1468.
20. Kami M, Matsumura T, Tanaka Y, et al. Serum levels of soluble interleukin-2 receptor after bone marrow transplantation: a true marker of acute graft-versus-host disease. Leuk Lymphoma. 2000;38:533-540.
21. Heitger A, Greinix H, Mannhalter C, et al. Requirement of residual thymus to restore normal T-cell subsets after human allogeneic bone marrow transplantation. Transplantation. 2000;69:2366-2373.
22. Miyamoto T, Akashi K, Hayashi S, et al. Serum concentration of the soluble interleukin-2 receptor for monitoring acute graft-versus-host disease. Bone Marrow Transplant. 1996;17:185-190.
23. Mathias C, Mick R, Grupp S, et al. Soluble interleukin-2 receptor concentration as a biochemical indicator for acute graft-versus-host disease after allogeneic bone marrow transplantation. J Hematother Stem Cell Res. 2000;9:393-400.
24. Hintzen RQ, de Joug R, Hack CE, et al. A soluble form of the human T cell differentiation antigen CD27 is released after triggering of theTCR/CD3 complex. J Immunol. 1991;147:29-35.
25. Hebib NC, Deas O, Rouleau M, et al. Peripheral blood T cells generated after allogeneic bone marrow transplantation: lower levels of bcl-2 protein and enhanced sensitivity to spontaneous and CD95-mediated apoptosis in vitro. Abrogation of the apoptotic phenotype coincides with the recovery of normal naive/primed T-cell profile. Blood. 1999;94:1803-1813.
26. Lin M-T, Tseng L-H, Frabgoul H, et al. Increased apoptosis of peripheral blood T cells following allogeneic hematopoietic cell transplantation. Blood. 2000;95:3832-3839.
27. Horikawa M, Matsunai T, Saitoh H, et al. Distinct TCRAV and TCRBV repertoire and CDR3 sequence of T lymphocytes clonally expanded in blood and GVHD lesions after human allogeneic bone marrow transplantation. Bone Marrow Transplant. 2002;30:915-923.
28. Margolis DA, Casper JT, Segura AD, et al. Infiltrating T cells during liver graft-versus-host disease show a restricted T-cell repertoire. Biol Blood Marrow Transplant. 2000;6:408-415.
29. + T cells do not induce graft-versus-host disease. J Clin Invest. 2003;112:101-108.
30. - memory T cells without graft-versus-host disease. Blood. 2004;103:1534-1541.
31. Lampert IA, Suitters AJ, Chisholm PM. Expression of Ia antigen on epidermal keratinocytes in graft-versus-host disease. Nature. 1981;293:149-150.
32. Mason DW, Dallman M, Barcloug AN. Graft-versus-host disease induces expression of Ia antigen in rat epidermal cells and gut epithelium. Nature. 1981;293:150-151.
33. + T cell-mediated graft-versus-host disease. J Clin Invest. 2003;112:1880-1886.
34. Dutt S, Emann J, Tseng D, et al. L-selectin and β7 integrin on donor CD4 T cells are required for the early migration to host mesenteric lymph nodes and acute colitis of graft-versus-host disease. Blood. 2005;106:4009-4015.
35. Yu X-Z, Albert MH, Anasetti C. Alloantigen affinity and CD4 help determine severity of graft-versus-host disease mediated by CD8 donor T cells. J Immunol. 2006;176:3383-3390.
36. De Rosa SC, Herzenberg LA, Roederer M. 11-color 13-parameter flow cytometry: identification of human naive T cells by phenotype, function, and T-cell receptor diversity. Nat Med. 2001;7:245-248.